Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (131-140 of 263) with videos related to

Pageof 27
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 17, 2005
Substrate specific metabolism by polymorphic cytochrome P450 2D6 allelesAlessia Bogni, Mario Monshouwer, Anna Moscone, et al.
Biochimie|August 22, 2012
DNA methylation dynamics in the hepatic CYP3A4 gene promoterMarina Kacevska, Maxim Ivanov, Annika Wyss, et al.
Pharmacological Reviews|October 16, 2024
The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet-Examples of Recent Accomplishments and Future PerspectivesEddie Weitzberg, Magnus Ingelman-Sundberg, Jon O Lundberg, et al.
European Journal of Clinical Pharmacology|July 4, 2024
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivoElisabet Størset, Line Skute Bråten, Magnus Ingelman-Sundberg, et al.
Human Mutation|February 20, 2004
A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activityMarià Pitarque, Oliver von Richter, Cristina Rodríguez-Antona, et al.
Plos One|April 7, 2015
Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumorsEva Choong, Jia Guo, Anna Persson, et al.
Carcinogenesis|May 3, 2003
Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer riskSara Wedrén, Tove Rylander Rudqvist, Fredrik Granath, et al.
Molecular Pharmacology|August 3, 2010
Regulation of CYP2C19 expression by estrogen receptor α: implications for estrogen-dependent inhibition of drug metabolismJessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, et al.
British Journal of Clinical Pharmacology|March 24, 2023
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolismBirgit M Wollmann, Robert L Smith, Marianne Kristiansen Kringen, et al.
Chemical Research in Toxicology|September 24, 2016
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug CandidatesVolker M Lauschke, Delilah F G Hendriks, Catherine C Bell, et al.
Pageof 27

Showing results (131-140 of 263) with videos related to

Sort By:
Pageof 27
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 17, 2005
Substrate specific metabolism by polymorphic cytochrome P450 2D6 allelesAlessia Bogni, Mario Monshouwer, Anna Moscone, et al.
Biochimie|August 22, 2012
DNA methylation dynamics in the hepatic CYP3A4 gene promoterMarina Kacevska, Maxim Ivanov, Annika Wyss, et al.
Pharmacological Reviews|October 16, 2024
The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet-Examples of Recent Accomplishments and Future PerspectivesEddie Weitzberg, Magnus Ingelman-Sundberg, Jon O Lundberg, et al.
European Journal of Clinical Pharmacology|July 4, 2024
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivoElisabet Størset, Line Skute Bråten, Magnus Ingelman-Sundberg, et al.
Human Mutation|February 20, 2004
A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activityMarià Pitarque, Oliver von Richter, Cristina Rodríguez-Antona, et al.
Plos One|April 7, 2015
Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumorsEva Choong, Jia Guo, Anna Persson, et al.
Carcinogenesis|May 3, 2003
Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer riskSara Wedrén, Tove Rylander Rudqvist, Fredrik Granath, et al.
Molecular Pharmacology|August 3, 2010
Regulation of CYP2C19 expression by estrogen receptor α: implications for estrogen-dependent inhibition of drug metabolismJessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, et al.
British Journal of Clinical Pharmacology|March 24, 2023
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolismBirgit M Wollmann, Robert L Smith, Marianne Kristiansen Kringen, et al.
Chemical Research in Toxicology|September 24, 2016
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug CandidatesVolker M Lauschke, Delilah F G Hendriks, Catherine C Bell, et al.
Pageof 27